Gregg Lapointe

AstenJohnson, Inc. manufactures paper machine clothing, specialty fabrics, filaments, and drainage equipment. Its products include pulp mill and paper mill. The company was founded in 1999 and is headquartered in Charleston, SC.

The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT.

Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

The Signature Group, Inc. (Virginia) provides information technology consulting and management services. Its services are targeted towards enterprise class clients, small and medium size businesses, the telecommunication industry, associations and non-profits, as well as federal, state, and local governments. The firm provides information technology consulting, design, project management, implementation and support services. The Signature Group was founded by Rochelle Bratton and Michael C. Perdue in 1986 and is headquartered in Vienna, VA.

Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA.

Cerium Pharmaceuticals, Inc. develops and commercializes medicines for rare and ultra-rare diseases. The company was founded by Gregg Anthony Lapointe and is headquartered in Gaithersburg, MD.

S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY.

Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA.